Such action may also affect CTCF-driven TAD resulting in disruption of TAD-mediated enhancer/promoter communications and the oncogenic transcription program, such as that of the TAL1 oncogene in T-ALL, eventually blocking leukemogenesis. This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.